For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
We are seeking an Intern for Summer 2019 for our Safety Assessment site located in Reno, NV.
Our Intern will be partnered with one our own site scientists and learn about the Safety Assessment process. The Intern will also have the opportunity to work with others on the site on various aspects of the Charles River process. And at the end of the term, the Intern will conduct a presentation to members of the staff to show what they have learned.
The following are minimum requirements related to the Summer Intern position.
Student currently enrolled in an accredited college/university degree program pursuing a Bachelor's degree in Biology, Chemistry, Biotechnology, or related scientific field.
Completion of Sophomore year
Minimum GPA of 2.8
Ability to fulfill a minimum of a 12 week internship within May – August time period
Ability to work approximately forty (40) hours per week during this period
Effective communication and listening skills in a teamwork environment
Demonstrated ability to work on multiple projects with a strong attention to detail
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.